EP1680167A1 - Combined positive and negative pressure assist ventilation - Google Patents

Combined positive and negative pressure assist ventilation

Info

Publication number
EP1680167A1
EP1680167A1 EP04789758A EP04789758A EP1680167A1 EP 1680167 A1 EP1680167 A1 EP 1680167A1 EP 04789758 A EP04789758 A EP 04789758A EP 04789758 A EP04789758 A EP 04789758A EP 1680167 A1 EP1680167 A1 EP 1680167A1
Authority
EP
European Patent Office
Prior art keywords
patient
negative pressure
positive
level
pressure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP04789758A
Other languages
German (de)
French (fr)
Other versions
EP1680167B1 (en
EP1680167A4 (en
Inventor
Christer Sinderby
Jennifer Beck
Christer Ström
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Maquet Critical Care AB
Original Assignee
Maquet Critical Care AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Maquet Critical Care AB filed Critical Maquet Critical Care AB
Publication of EP1680167A1 publication Critical patent/EP1680167A1/en
Publication of EP1680167A4 publication Critical patent/EP1680167A4/en
Application granted granted Critical
Publication of EP1680167B1 publication Critical patent/EP1680167B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61HPHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H31/00Artificial respiration or heart stimulation, e.g. heart massage
    • A61H31/02"Iron-lungs", i.e. involving chest expansion by applying underpressure thereon, whether or not combined with gas breathing means
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/021Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes operated by electrical means
    • A61M16/022Control means therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61HPHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H31/00Artificial respiration or heart stimulation, e.g. heart massage
    • A61H31/02"Iron-lungs", i.e. involving chest expansion by applying underpressure thereon, whether or not combined with gas breathing means
    • A61H2031/025"Iron-lungs", i.e. involving chest expansion by applying underpressure thereon, whether or not combined with gas breathing means using the same pump for pressure and vacuum, not being driven at the respiratory rate, e.g. blowers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61HPHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H2201/00Characteristics of apparatus not provided for in the preceding codes
    • A61H2201/50Control means thereof
    • A61H2201/5058Sensors or detectors
    • A61H2201/5061Force sensors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61HPHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H2205/00Devices for specific parts of the body
    • A61H2205/08Trunk
    • A61H2205/083Abdomen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00Measuring parameters of the user
    • A61M2230/08Other bio-electrical signals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00Measuring parameters of the user
    • A61M2230/60Muscle strain, i.e. measured on the user

Definitions

  • the present invention relates to combined positive and negative pressure assist ventilation of a patient.
  • Mechanical assist ventilation is delivered to a patient in order to maintain adequate alveolar ventilation by partially or totally substituting the function of the presumably weak or failing respiratory muscle(s).
  • a negative pressure around the patient's ribcage and/or abdomen the so-called negative pressure assist ventilation.
  • negative pressure assist ventilation creates a partial vacuum around the patient's ribcage and/or abdomen to induce inspiration. This mode of mechanical assist ventilation proved useful, but restricted physical access to the patient during ventilation.
  • excessive inspiratory loads imposed by the patient's abdomen and/or ribcage may occur with obesity, reduced compliance due to abdominal distension, dynamic hyperinflation, and/or deformities of the chest wall.
  • a method of delivering combined positive and negative pressure assist ventilation to a patient comprising applying a positive pressure to the patient's airways to inflate the patient's lungs, applying a negative pressure around the patient's ribcage and/or abdomen in order to reduce a load imposed by the ribcage and/or abdomen on the patient's lungs, and synchronizing application of the positive and negative pressures.
  • the present invention also relates to a system for delivering combined positive and negative pressure assist ventilation to a patient, comprising first means for applying a positive pressure to the patient's airways to inflate the patient's lungs, second means for applying a negative pressure around the patient's ribcage and/or abdomen in order to reduce a load imposed by the ribcage and/or abdomen on the patient's lungs, and means for synchronizing operation of the first and second pressure-applying means.
  • the present invention is further concerned with a system for delivering combined positive and negative pressure assist ventilation to a patient, comprising a positive pressure ventilator connected to the patient's airways for applying a positive pressure to the patient's airways to inflate the patient's lungs, a negative pressure ventilator installed on the patient's ribcage and/or abdomen for applying a negative pressure around the patient's ribcage and/or abdomen in order to reduce a load imposed by the ribcage and/or abdomen on the patient's lungs, and a controller for synchronising operation of the positive and negative pressure ventilators.
  • a positive pressure ventilator connected to the patient's airways for applying a positive pressure to the patient's airways to inflate the patient's lungs
  • a negative pressure ventilator installed on the patient's ribcage and/or abdomen for applying a negative pressure around the patient's ribcage and/or abdomen in order to reduce a load imposed by the ribcage and/or abdomen on the patient's
  • Figure 1 is a flow chart of a non-restrictive illustrative embodiment of the method according to the present invention, for applying both a positive pressure to the patient's airways in order to inflate the lungs and a negative pressure around the patient's ribcage and/or abdomen in order to reduce the load imposed by the ribcage and/or abdomen on the lungs;
  • Figure 2 is a block diagram of a non-restrictive illustrative embodiment of the system according to the present invention, for applying both a positive pressure to the patient's airways in order to inflate the lungs and a negative pressure around the patient's ribcage and/or abdomen in order to reduce the load imposed by the ribcage and/or abdomen on the lungs;
  • Figure 3 is a side elevational view of an example of negative pressure ventilator
  • Figure 4 is a flow chart of a first non-restrictive illustrative embodiment of process for applying the positive pressure to the patient's airways in order to inflate the lungs;
  • Figure 5 is a flow chart of a second non-restrictive illustrative embodiment of process for applying the positive pressure to the patient's airways in order to inflate the lungs;
  • Figure 6 is a flow chart of a first non-restrictive illustrative embodiment of process for applying a negative pressure around the patient's ribcage and/or abdomen in order to reduce the load imposed by the ribcage and/or abdomen on the lungs;
  • Figure 7 is a flow chart of a second non-restrictive illustrative embodiment of process for applying a negative pressure around the patient's ribcage and/or abdomen in order to reduce the load imposed by the ribcage and/or abdomen on the lungs;
  • Figure 8 is a flow chart of a third non-restrictive illustrative embodiment of process for applying a negative pressure around the patient's ribcage and/or abdomen in order to reduce the load imposed by the ribcage and/or abdomen on the lungs.
  • a positive pressure is applied to the patient's lungs in order to inflate the lungs and a negative pressure is applied around the patient's ribcage and/or abdomen to reduce the load imposed by the ribcage and/or abdomen on the lungs.
  • the method according to the non-restrictive illustrative embodiment of i the present invention comprises, as illustrated in Figure 1 , the following operations:
  • Positive pressure is applied to the patient's airways to deliver assist ventilation, i.e. to substitute respiratory muscles' work to inflate the lungs.
  • negative pressure is applied around the patient's ribcage and/or abdomen to reduce the load imposed by the ribcage and/or abdomen on the lungs. More specifically, the negative pressure assist substitutes for respiratory muscles' work to displace the patient's ribcage and/or abdomen.
  • This operation consists of synchronizing application of positive pressure to the patient's airways and negative pressure to the patient's ribcage and/or abdomen.
  • the operations 101-103 of Figure 1 can be performed through the system of Figures 2 and 3.
  • the system of Figure 2 for delivering combined positive and negative pressure assist ventilation to a patient first comprises a positive pressure ventilator 201 for applying positive pressure assist ventilation (flow and/or volume) required to overcome the elastic and resistive loads related to inflation of the patient's lungs. More specifically, the positive pressure ventilator 201 will apply a positive pressure to the patient's airways to inflate the patient's lungs.
  • positive pressure assist ventilation are described in US Patent No. 5,820,560 granted to Sinderby et al on October 13, 1998 and US Patent No. 6,588,423 (Sinderby) issued on July 8, 2003. The subject matter of these two US patents is herein incorporated by reference.
  • the system of Figure 2 further comprises a negative pressure ventilator
  • the negative pressure ventilator 202 structured for applying a negative pressure (flow and/or volume) around the patient's ribcage and/or abdomen to cancel and/or reduce the load caused by the ribcage and/or abdomen on the patient's lungs.
  • a negative pressure ventilator 202 comprises a ventilator shell 301 , a patient 302 requiring negative pressure ventilatory assist wearing this ventilator shell 301.
  • any other device for delivering negative pressure could of course be used in combination with the neural controller 203 of Figure 2, e.g. a cuirass, an iron lung, a poncho, etc.
  • the device for delivering negative pressure does not need to be leak proof since the neural controller such as 203 will compensate for such leak.
  • the ventilator shell 301 extends over the ribcage and abdomen area of the patient 302 and consists of two half-shell sections 303 and 304 that are not identical but respectively shaped to serve as ventral and dorsal half-shell sections. As illustrated in Figure 3, the half-shell sections 303 and 304 co- operate to enclose the major portion of the ribcage and abdomen of the patient 302.
  • the shell sections 303 and 304 are firmly secured together on opposite sides of the patient's body by respective pairs of clamps 305.
  • sealing lips 306 are intended to press against the skin of the patient 302 and thereby bound an airtight chamber 307 within the shell 301 for application of a negative pressure to the patient's ribcage and abdomen.
  • Seals such as 308 are provided for sealing the joints between the two half-shell sections 303 and 304 on the opposite sides of the patient's body, thereby making these joints airtight.
  • the ventilator 202 produces a negative pressure or vacuum in the chamber 307 to cancel and/or reduce the load of the patient's ribcage and abdomen on the lungs.
  • the negative pressure or vacuum is applied to the chamber 307 through a port 309 in the ventral half-shell section 303.
  • Negative pressure ventilators are believed to be otherwise well known to those of ordinary skill in the art and accordingly will not be further described in the present specification.
  • the system of Figure 2 further comprises a controller 203 used to control the positive and negative pressure ventilators 201 and 202.
  • the controller 203 synchronizes triggering and termination of the application, during inspiration, of positive pressure to the patient's airways and negative pressure around the patient's ribcage and/or abdomen.
  • the controller 203 derives triggering and termination signals 204 and 208 applied to the ventilators 201 and 202, respectively.
  • the signals 204 and 208 can be derived from neural inspiratory activation, for example electrical activity of the patient's diaphragm or other respiratory-related muscle, detected through a sensor 205.
  • a non-restrictive example of neural triggering and termination of assist ventilation is described in the above mentioned US Patent No. 6,588,423 granted Sinderby on July 8, 2003.
  • the level of positive pressure applied to the patient's lungs during inspiration can be manually set by the medical personnel or adjusted as a function of the neural inspiratory activation, for example the electrical activity of the patient's diaphragm or other respiration-related muscle.
  • the controller 203 produces a positive pressure level control signal 209 for example in response to the electrical activity of the patient's diaphragm or other respiratory-related muscle as detected by the sensor 205.
  • the signal 209 controls the ventilator 201 to adjust the level of assist ventilation positive pressure Oto the required level.
  • the level of positive pressure applied to the patient's lungs will be adjusted in proportion to the level of electrical activity of the patient's diaphragm or other respiratory-related muscle.
  • An example of positive pressure assist level adjustment is described in the above mentioned US Patent No. 5,820,560 granted to Sinderby et al on October 13, 1998.
  • the level of negative pressure applied around the patient's ribcage and/or abdomen can be adjusted as a fraction of the positive pressure delivered to the patient; alternatively, 50% of the pressure target can be delivered to the patient as positive pressure and the other 50% of the pressure target can be delivered as negative pressure.
  • a more physiological approach would be to use feedback from the abdominal pressure.
  • the controller 203 produces, for that purpose, a negative pressure level control signal 210 applied to the negative pressure ventilator 202.
  • the abdominal pressure feedback supplied to the controller 203 for producing the signal 210 and controlling the level of negative pressure applied around the patient's ribcage and/or abdomen could be obtained via a pressure sensor 206 located, for example, in the stomach/upper intestines, urine bladder, rectum/lower intestines, etc. This process will be described in detail in the following description.
  • the abdominal pressure can be measured, for example, through a small gastric balloon mounted on an esophageal catheter and inserted in the stomach/upper intestines.
  • This small gastric balloon inflated with gas, will be subjected to the abdominal pressure and associated with an outside gas pressure detector for detecting this abdominal pressure.
  • pressure can be measured through an extrapulmonary pressure sensor 207.
  • This extrapulmonary pressure sensor 207 will be located, for example, in the patient's esophagus or pleural space.
  • this extrapulmonary pressure sensor 207 can comprise a small balloon mounted on an esophageal catheter and inserted in the patient's esophagus or pleural space.
  • This small balloon inflated with gas, will be subjected to the intrathoracic pressure and associated with an outside gas pressure detector for detecting the transpulmonary pressure.
  • Application of negative pressure can then be quantified with respect to how much it reduces transpulmonary pressure i.e. the pressure distending lung including airways and alveoli.
  • an intrathoracic pressure estimate could be obtained by measuring an airway pressure deflection during a patient's airway occlusion.
  • this includes an extrapolation for the period between the onset of electrical activity of the patient's diaphragm activity and the onset of the patient's airway pressure deflection.
  • the abdominal pressure can be measured through any other suitable means known to those of ordinary skill in the art and capable of measuring abdominal pressure from locations as various as the patient's airways, esophageus, pleural space, stomach/upper intestines, urine bladder, rectum/lower intestines, etc.
  • Application of positive pressure assist ventilation (101 of Figure 1)
  • neural inspiratory activation is detected through the sensor 205 of Figure 2.
  • the sensor 205 can detect electrical activity of the patient's diaphragm or other respiratory-related muscle.
  • a non-limitative example of detection of the electrical activity of the patient's diaphragm is described in the above mentioned US Patent No. 5,820,560 granted to Sinderby et al on October 13, 1998.
  • the controller 203 controls the positive pressure ventilator 201 through the level control signal 209 to apply to the patient's airways a level of positive pressure adjusted as a function of the detected neural inspiratory activation, for example the electrical activity of the patient's diaphragm or other respiratory-related muscle.
  • a level of positive pressure applied to the patient's airways can be proportional to the detected level of neural inspiratory activation.
  • inspiratory proportional pressure assist ventilation is described in the above mentioned US Patent No. 5,820,560 granted to Sinderby et al on October 13, 1998.
  • the controller 203 synchronizes the triggering and termination of the cyclically induced positive pressure assist ventilation to the patient's spontaneous breathing.
  • the controller 203 derives the triggering and termination signal 204, applied to the ventilator 201 , from the neural inspiratory activation for example the electrical activity of the patient's diaphragm or other respiratory-related muscle detected through the sensor 205.
  • a non-restrictive example of neural triggering and termination of assist ventilation is described in the above mentioned US Patent No. 6,588,423 granted Sinderby on July 8, 2003.
  • Operations 401-403 can be performed every inspiratory cycle.
  • the inspiratory cycle can be divided into a plurality of segments and operations 401 and 402 can be performed every cycle segment.
  • the non-limitative process of Figure 5 first determines a target level of the neural inspiratory activation, for example the electrical activity of the patient's diaphragm or other respiratory-related muscle.
  • this target level can be determined by the medical personnel for each individual patient depending on the condition of the patient. Operation 502
  • the sensor 205 of Figure 2 detects the patient's neural inspiratory activation, for example the electrical activity of the patient's diaphragm or other respiratory-related muscle.
  • Operation 503 If the controller 203 determines that the detected patient's neural inspiratory activation (Operation 502) is higher than the target level of neural inspiratory activation (Operation 501), operation 504 is performed. Operation 504
  • the level of positive pressure applied to the patient's airways is increased, for example by a predetermined step. Operation 505
  • Operation 506 is performed.
  • Operation 506 The level of positive pressure applied to the patient's airways is decreased, for example by a predetermined step.
  • Operation 507 If the controller 203 determines that the detected patient's neural inspiratory activation (Operation 502) is equal to the target level or within an acceptable range of the target level of the patient's neural inspiratory activation (Operation 501), Operation 508 is performed. Operation 508 The level of positive pressure applied to the patient's airways is not changed.
  • the controller 203 synchronizes the triggering and termination of the cyclically induced positive pressure assist ventilation to the patient's spontaneous breathing.
  • the controller 203 derives the triggering and termination signal 204, applied to the ventilator 201 , from the neural inspiratory activation for example the electrical activity of the patient's diaphragm or other respiratory-related muscle detected through the sensor 205 (Operation 502).
  • the neural inspiratory activation for example the electrical activity of the patient's diaphragm or other respiratory-related muscle detected through the sensor 205 (Operation 502).
  • a non-restrictive example of neural triggering and termination of assist ventilation is described in the above mentioned US Patent No. 6,588,423 granted Sinderby on July 8, 2003.
  • Operations 502-508 can be performed every inspiratory cycle.
  • the inspiratory cycle can be divided into a plurality of segments and operations 502-508 can be performed every cycle segment.
  • operations 502-508 can also be applied for time segments longer than one inspiratory cycle.
  • the simplest method for applying negative pressure around the patient's ribcage and/or abdomen consists of applying a fixed negative pressure around the ribcage and/or abdomen of the patient during inspiration and/or expiration.
  • Operation 602 Triggering and termination of the application of negative pressure around the patient's ribcage and/or abdomen is synchronized with triggering and termination of the application of positive pressure to the patient's airways.
  • Operations 601 and 602 can be performed every inspiratory cycle.
  • the negative pressure application in 601 is not restricted to inspiration only; negative pressure can also be applied during the expiratory phase, where the magnitude of the negative pressure does not have to be same as during the inspiratory phase.
  • neural inspiratory activation is detected through the sensor 205 of Figure 2.
  • the sensor 205 can detect electrical activity of the patient's diaphragm or other respiratory-related muscle. Operation 702
  • the controller 203 controls the negative pressure ventilator 202 through the level control signal 210 to apply a level of negative pressure around the patient's ribcage and/or abdomen as a function of the detected neural inspiratory activation, for example the electrical activity of the patient's diaphragm.
  • the level of the negative pressure applied around the patient's ribcage and/or abdomen can be proportional to the detected level of neural inspiratory activation.
  • inspiratory proportional pressure assist ventilation is described in the above mentioned US Patent No. 5,820,560 granted to Sinderby et al on October 13, 1998.
  • Triggering and termination of the application of negative pressure around the patient's ribcage and/or abdomen is synchronized with triggering and termination of the application of positive pressure to the patient's airways.
  • Operations 701-703 can be performed every inspiratory cycle.
  • the inspiratory cycle can be divided into a plurality of segments and operations 701 and 702 can be performed every cycle segment.
  • the non-limitative process of Figure 8 first determines a target level of abdominal pressure swing of the patient.
  • the abdominal pressure swing is the variation of abdominal pressure during a complete cycle of inspiration.
  • the target level of abdominal pressure swing can be determined on the basis of previously measured absolute, peak, mean and/or area/integral values of abdominal pressure swings with or without a range.
  • the objective is to control the negative pressure assist ventilation so as to reduce the abdominal pressure swing during inspiration.
  • this is achieved by setting a target level of abdominal pressure swing.
  • the pressure sensor 206 of Figure 2 detect the patient's abdominal pressure during inspiration, using any method known to those of ordinary skill in the art, including those as described in the foregoing description.
  • the patient's abdominal pressure swing is determined by the controller 203 from the patient's abdominal pressure detected during inspiration through the pressure sensor 206 of Figure 2 (Operation 801). Operation 804
  • Operation 805 is conducted.
  • Operation 805 The level of negative pressure applied around the ribcage and/or abdomen is increased, for example by a predetermined step.
  • Operation 807 is performed. Operation 807
  • the level of negative pressure applied around the ribcage and/or abdomen is decreased, for example by a predetermined step. Operation 808
  • Operation 809 is performed.
  • the level of negative pressure applied around the ribcage and/or abdomen is not changed.
  • Triggering and termination of the application ot negative pressure around the patient's ribcage and/or abdomen is synchronized with triggering and termination of the application of positive pressure to the patient's airways.
  • Operations 802-810 can be performed every inspiratory cycle.
  • the inspiratory cycle can be divided into a plurality of segments and operations 802-809 can be performed every cycle segment.
  • operations 802-810 can be performed during time periods longer than one inspiratory cycle.
  • NEEP can be applied over the abdomen to adjust the end- expiratory lung-volume.
  • NEEP can be applied in combination with inspiratory negative pressure assist ventilation or alone.
  • NEEP can also be delivered in proportional response to tonic inspiratory muscle, for example the diaphragm, activation occurring during expiration.
  • a device for carrying out combined positive and negative pressure assist ventilation will not obstruct patient access as negative pressure ventilation alone would, since the positive pressure ventilation could assume 100% of the assist while the negative pressure device is removed during patient access.
  • the negative pressure applied around the patient's ribcage and/or abdomen eliminates both the load caused by the ribcage and/or abdomen on the patient's lungs and, thereby, the need for excessive positive pressure applied to the patient's airways.
  • Cyclic and/or proportional application of negative pressure around the abdomen facilitates diaphragm movement and hence, reduces the risk for airway collapse in the dependent regions of the lungs.
  • the positive and negative pressures can be adjusted to avoid application of excessive positive pressure to the patient's airways, and therefore to minimize hemodynamic adverse effects. Monitoring of hemodynamics will help to optimize the level of the negative pressure assist as well as the relative contribution of the positive and negative pressure assists in order to minimize these hemodynamic adverse effects.

Abstract

The present invention relates to a method of delivering combined positive and negative pressure assist ventilation to a patient, wherein a positive pressure is applied to the patient's airways to inflate the patient's lungs, a negative pressure is applied around the patient's ribcage and/or abdomen in order to reduce a load imposed by the ribcage and/or abdomen on the patient's lungs, and application of the positive and negative pressures is synchronized. The present invention also relates to a system for delivering combined positive and negative pressure assist ventilation to a patient, comprising a positive pressure ventilator connected to the patient's airways for applying a positive pressure to the patient's airways to inflate the patient's lungs, a negative pressure ventilator installed on the patient's ribcage and/or abdomen for applying a negative pressure around the patient's ribcage and/or abdomen in order to reduce a load imposed by the ribcage and/or abdomen on the patient's lungs, and a controller for synchronising operation of the positive and negative pressure ventilators.

Description

COMBINED POSITIVE AND NEGATIVE PRESSURE ASSIST VENTILATION
FIELD OF THE INVENTION
The present invention relates to combined positive and negative pressure assist ventilation of a patient.
BACKGROUND OF THE INVENTION
Mechanical assist ventilation is delivered to a patient in order to maintain adequate alveolar ventilation by partially or totally substituting the function of the presumably weak or failing respiratory muscle(s). Initially, it was found preferable to deliver mechanical assist ventilation to a patient by applying a negative pressure around the patient's ribcage and/or abdomen; the so-called negative pressure assist ventilation. In fact, negative pressure assist ventilation creates a partial vacuum around the patient's ribcage and/or abdomen to induce inspiration. This mode of mechanical assist ventilation proved useful, but restricted physical access to the patient during ventilation.
Nowadays, mechanical assist ventilation is delivered, with a few exceptions, by applying a positive pressure to the patient's airways; the so- called positive pressure assist ventilation. In order to completely unload the patient's inspiratory muscles with positive pressure assist ventilation, it is necessary to apply a positive pressure that is capable not only to inflate the lungs, but also to displace the chest wall and the abdomen. In practice, this requires application of a positive pressure exceeding the transpulmonary pressure; the transpulmonary pressure is the pressure required to inflate the patient's lungs alone. A high inspiratory positive assist pressure increases the risk for barotrauma and pneumothorax, and can have a negative effect on hemodynamics.
Also, excessive inspiratory loads imposed by the patient's abdomen and/or ribcage may occur with obesity, reduced compliance due to abdominal distension, dynamic hyperinflation, and/or deformities of the chest wall.
Obviously, higher inspiratory positive assist pressure supplied to the patient's airways is required to overcome these additional inspiratory loads. Finally, the current commercially available modes of both positive and negative pressure assist ventilation presents the following limitation: the pneumatic system, designed to respond to the patient's effort, induces a time lag that can influence the patient's breathing pattern, leading to deterioration of the patient-ventilator synchrony. This situation is often referred to as the patient "fighting the ventilator". In order to avoid the patient "fighting the ventilator", increased patient sedation and even respiratory muscle paralysis is often required.
SUMMARY OF THE INVENTION
In accordance with the present invention, there is provided a method of delivering combined positive and negative pressure assist ventilation to a patient, comprising applying a positive pressure to the patient's airways to inflate the patient's lungs, applying a negative pressure around the patient's ribcage and/or abdomen in order to reduce a load imposed by the ribcage and/or abdomen on the patient's lungs, and synchronizing application of the positive and negative pressures. The present invention also relates to a system for delivering combined positive and negative pressure assist ventilation to a patient, comprising first means for applying a positive pressure to the patient's airways to inflate the patient's lungs, second means for applying a negative pressure around the patient's ribcage and/or abdomen in order to reduce a load imposed by the ribcage and/or abdomen on the patient's lungs, and means for synchronizing operation of the first and second pressure-applying means.
The present invention is further concerned with a system for delivering combined positive and negative pressure assist ventilation to a patient, comprising a positive pressure ventilator connected to the patient's airways for applying a positive pressure to the patient's airways to inflate the patient's lungs, a negative pressure ventilator installed on the patient's ribcage and/or abdomen for applying a negative pressure around the patient's ribcage and/or abdomen in order to reduce a load imposed by the ribcage and/or abdomen on the patient's lungs, and a controller for synchronising operation of the positive and negative pressure ventilators.
The foregoing and other objects, advantages and features of the present invention will become more apparent upon reading of the following non restrictive description of illustrative embodiments thereof, given by way of example only with reference to the accompanying drawings.
BRIEF DESCRIPTION OF THE DRAWINGS
In the appended drawings:
Figure 1 is a flow chart of a non-restrictive illustrative embodiment of the method according to the present invention, for applying both a positive pressure to the patient's airways in order to inflate the lungs and a negative pressure around the patient's ribcage and/or abdomen in order to reduce the load imposed by the ribcage and/or abdomen on the lungs; Figure 2 is a block diagram of a non-restrictive illustrative embodiment of the system according to the present invention, for applying both a positive pressure to the patient's airways in order to inflate the lungs and a negative pressure around the patient's ribcage and/or abdomen in order to reduce the load imposed by the ribcage and/or abdomen on the lungs;
Figure 3 is a side elevational view of an example of negative pressure ventilator; Figure 4 is a flow chart of a first non-restrictive illustrative embodiment of process for applying the positive pressure to the patient's airways in order to inflate the lungs;
Figure 5 is a flow chart of a second non-restrictive illustrative embodiment of process for applying the positive pressure to the patient's airways in order to inflate the lungs;
Figure 6 is a flow chart of a first non-restrictive illustrative embodiment of process for applying a negative pressure around the patient's ribcage and/or abdomen in order to reduce the load imposed by the ribcage and/or abdomen on the lungs;
Figure 7 is a flow chart of a second non-restrictive illustrative embodiment of process for applying a negative pressure around the patient's ribcage and/or abdomen in order to reduce the load imposed by the ribcage and/or abdomen on the lungs; and
Figure 8 is a flow chart of a third non-restrictive illustrative embodiment of process for applying a negative pressure around the patient's ribcage and/or abdomen in order to reduce the load imposed by the ribcage and/or abdomen on the lungs. BRIEF DESCRIPTION OF THE ILLUSTRATIVE EMBODIMENT
In accordance with the non-restrictive illustrative embodiment of the method according to the present invention, a positive pressure is applied to the patient's lungs in order to inflate the lungs and a negative pressure is applied around the patient's ribcage and/or abdomen to reduce the load imposed by the ribcage and/or abdomen on the lungs. The method according to the non-restrictive illustrative embodiment of i the present invention comprises, as illustrated in Figure 1 , the following operations:
Operation 101
Positive pressure is applied to the patient's airways to deliver assist ventilation, i.e. to substitute respiratory muscles' work to inflate the lungs.
Operation 102
Along with operation 101 , negative pressure is applied around the patient's ribcage and/or abdomen to reduce the load imposed by the ribcage and/or abdomen on the lungs. More specifically, the negative pressure assist substitutes for respiratory muscles' work to displace the patient's ribcage and/or abdomen.
Operation 103
This operation consists of synchronizing application of positive pressure to the patient's airways and negative pressure to the patient's ribcage and/or abdomen. The operations 101-103 of Figure 1 can be performed through the system of Figures 2 and 3.
The system of Figure 2, for delivering combined positive and negative pressure assist ventilation to a patient first comprises a positive pressure ventilator 201 for applying positive pressure assist ventilation (flow and/or volume) required to overcome the elastic and resistive loads related to inflation of the patient's lungs. More specifically, the positive pressure ventilator 201 will apply a positive pressure to the patient's airways to inflate the patient's lungs. Non-restrictive examples of positive pressure assist ventilation are described in US Patent No. 5,820,560 granted to Sinderby et al on October 13, 1998 and US Patent No. 6,588,423 (Sinderby) issued on July 8, 2003. The subject matter of these two US patents is herein incorporated by reference. The system of Figure 2 further comprises a negative pressure ventilator
202 structured for applying a negative pressure (flow and/or volume) around the patient's ribcage and/or abdomen to cancel and/or reduce the load caused by the ribcage and/or abdomen on the patient's lungs. Referring to Figure 3, an example of negative pressure ventilator 202 is illustrated. The negative pressure ventilator 202 comprises a ventilator shell 301 , a patient 302 requiring negative pressure ventilatory assist wearing this ventilator shell 301. Of course, any other device for delivering negative pressure could of course be used in combination with the neural controller 203 of Figure 2, e.g. a cuirass, an iron lung, a poncho, etc. Also, the device for delivering negative pressure does not need to be leak proof since the neural controller such as 203 will compensate for such leak.
The ventilator shell 301 extends over the ribcage and abdomen area of the patient 302 and consists of two half-shell sections 303 and 304 that are not identical but respectively shaped to serve as ventral and dorsal half-shell sections. As illustrated in Figure 3, the half-shell sections 303 and 304 co- operate to enclose the major portion of the ribcage and abdomen of the patient 302.
The shell sections 303 and 304 are firmly secured together on opposite sides of the patient's body by respective pairs of clamps 305.
At the two ends of the ventilator shell 301 , sealing lips 306 are intended to press against the skin of the patient 302 and thereby bound an airtight chamber 307 within the shell 301 for application of a negative pressure to the patient's ribcage and abdomen. Seals such as 308 are provided for sealing the joints between the two half-shell sections 303 and 304 on the opposite sides of the patient's body, thereby making these joints airtight.
The ventilator 202 produces a negative pressure or vacuum in the chamber 307 to cancel and/or reduce the load of the patient's ribcage and abdomen on the lungs. The negative pressure or vacuum is applied to the chamber 307 through a port 309 in the ventral half-shell section 303.
Negative pressure ventilators are believed to be otherwise well known to those of ordinary skill in the art and accordingly will not be further described in the present specification.
The system of Figure 2 further comprises a controller 203 used to control the positive and negative pressure ventilators 201 and 202.
Still referring to Figure 2, the controller 203 synchronizes triggering and termination of the application, during inspiration, of positive pressure to the patient's airways and negative pressure around the patient's ribcage and/or abdomen. For that purpose, the controller 203 derives triggering and termination signals 204 and 208 applied to the ventilators 201 and 202, respectively. The signals 204 and 208 can be derived from neural inspiratory activation, for example electrical activity of the patient's diaphragm or other respiratory-related muscle, detected through a sensor 205. A non-restrictive example of neural triggering and termination of assist ventilation is described in the above mentioned US Patent No. 6,588,423 granted Sinderby on July 8, 2003.
The level of positive pressure applied to the patient's lungs during inspiration can be manually set by the medical personnel or adjusted as a function of the neural inspiratory activation, for example the electrical activity of the patient's diaphragm or other respiration-related muscle. In the latter case, the controller 203 produces a positive pressure level control signal 209 for example in response to the electrical activity of the patient's diaphragm or other respiratory-related muscle as detected by the sensor 205. The signal 209 controls the ventilator 201 to adjust the level of assist ventilation positive pressure Oto the required level. For example, the level of positive pressure applied to the patient's lungs will be adjusted in proportion to the level of electrical activity of the patient's diaphragm or other respiratory-related muscle. An example of positive pressure assist level adjustment is described in the above mentioned US Patent No. 5,820,560 granted to Sinderby et al on October 13, 1998.
The level of negative pressure applied around the patient's ribcage and/or abdomen can be adjusted as a fraction of the positive pressure delivered to the patient; alternatively, 50% of the pressure target can be delivered to the patient as positive pressure and the other 50% of the pressure target can be delivered as negative pressure. A more physiological approach would be to use feedback from the abdominal pressure. The controller 203 produces, for that purpose, a negative pressure level control signal 210 applied to the negative pressure ventilator 202. The abdominal pressure feedback supplied to the controller 203 for producing the signal 210 and controlling the level of negative pressure applied around the patient's ribcage and/or abdomen could be obtained via a pressure sensor 206 located, for example, in the stomach/upper intestines, urine bladder, rectum/lower intestines, etc. This process will be described in detail in the following description.
The abdominal pressure can be measured, for example, through a small gastric balloon mounted on an esophageal catheter and inserted in the stomach/upper intestines. This small gastric balloon, inflated with gas, will be subjected to the abdominal pressure and associated with an outside gas pressure detector for detecting this abdominal pressure. Alternatively, pressure can be measured through an extrapulmonary pressure sensor 207. This extrapulmonary pressure sensor 207 will be located, for example, in the patient's esophagus or pleural space. Again, this extrapulmonary pressure sensor 207 can comprise a small balloon mounted on an esophageal catheter and inserted in the patient's esophagus or pleural space. This small balloon, inflated with gas, will be subjected to the intrathoracic pressure and associated with an outside gas pressure detector for detecting the transpulmonary pressure. Application of negative pressure can then be quantified with respect to how much it reduces transpulmonary pressure i.e. the pressure distending lung including airways and alveoli.
Moreover, an intrathoracic pressure estimate could be obtained by measuring an airway pressure deflection during a patient's airway occlusion. In case of intrinsic PEEP, this includes an extrapolation for the period between the onset of electrical activity of the patient's diaphragm activity and the onset of the patient's airway pressure deflection.
In fact, the abdominal pressure can be measured through any other suitable means known to those of ordinary skill in the art and capable of measuring abdominal pressure from locations as various as the patient's airways, esophageus, pleural space, stomach/upper intestines, urine bladder, rectum/lower intestines, etc. Application of positive pressure assist ventilation (101 of Figure 1)
First non-limitative example of process for controlling the level of positive pressure applied to the patient's airways (Figure 4)
Operation 401
According to this first non limitative example, neural inspiratory activation is detected through the sensor 205 of Figure 2. For example, the sensor 205 can detect electrical activity of the patient's diaphragm or other respiratory-related muscle. A non-limitative example of detection of the electrical activity of the patient's diaphragm is described in the above mentioned US Patent No. 5,820,560 granted to Sinderby et al on October 13, 1998.
Operation 402
The controller 203 controls the positive pressure ventilator 201 through the level control signal 209 to apply to the patient's airways a level of positive pressure adjusted as a function of the detected neural inspiratory activation, for example the electrical activity of the patient's diaphragm or other respiratory-related muscle. For example, the level of the positive pressure applied to the patient's airways can be proportional to the detected level of neural inspiratory activation. A non-restrictive example of inspiratory proportional pressure assist ventilation is described in the above mentioned US Patent No. 5,820,560 granted to Sinderby et al on October 13, 1998.
Operation 403
As described in the foregoing description, the controller 203 synchronizes the triggering and termination of the cyclically induced positive pressure assist ventilation to the patient's spontaneous breathing. For that purpose, the controller 203 derives the triggering and termination signal 204, applied to the ventilator 201 , from the neural inspiratory activation for example the electrical activity of the patient's diaphragm or other respiratory-related muscle detected through the sensor 205. A non-restrictive example of neural triggering and termination of assist ventilation is described in the above mentioned US Patent No. 6,588,423 granted Sinderby on July 8, 2003.
Operations 401-403 can be performed every inspiratory cycle. Alternatively, the inspiratory cycle can be divided into a plurality of segments and operations 401 and 402 can be performed every cycle segment.
Second non-limitative example of process for controlling the level of positive pressure applied to the patient's airways (Figure 5)
Operation 501
The non-limitative process of Figure 5 first determines a target level of the neural inspiratory activation, for example the electrical activity of the patient's diaphragm or other respiratory-related muscle. As a non-limitative example, this target level can be determined by the medical personnel for each individual patient depending on the condition of the patient. Operation 502
The sensor 205 of Figure 2 detects the patient's neural inspiratory activation, for example the electrical activity of the patient's diaphragm or other respiratory-related muscle.
Operation 503 If the controller 203 determines that the detected patient's neural inspiratory activation (Operation 502) is higher than the target level of neural inspiratory activation (Operation 501), operation 504 is performed. Operation 504
The level of positive pressure applied to the patient's airways is increased, for example by a predetermined step. Operation 505
If the controller 203 determines that the detected patient's neural inspiratory activation, for example the electrical activity of the patient's diaphragm or other respiratory-related muscle (Operation 502) is lower than the target level of neural inspiratory activation (Operation 501), Operation 506 is performed.
Operation 506 The level of positive pressure applied to the patient's airways is decreased, for example by a predetermined step.
Operation 507 If the controller 203 determines that the detected patient's neural inspiratory activation (Operation 502) is equal to the target level or within an acceptable range of the target level of the patient's neural inspiratory activation (Operation 501), Operation 508 is performed. Operation 508 The level of positive pressure applied to the patient's airways is not changed.
Operation 509
As described in the foregoing description, the controller 203 synchronizes the triggering and termination of the cyclically induced positive pressure assist ventilation to the patient's spontaneous breathing. For that purpose, the controller 203 derives the triggering and termination signal 204, applied to the ventilator 201 , from the neural inspiratory activation for example the electrical activity of the patient's diaphragm or other respiratory-related muscle detected through the sensor 205 (Operation 502). A non-restrictive example of neural triggering and termination of assist ventilation is described in the above mentioned US Patent No. 6,588,423 granted Sinderby on July 8, 2003.
Operations 502-508 can be performed every inspiratory cycle.
Alternatively, the inspiratory cycle can be divided into a plurality of segments and operations 502-508 can be performed every cycle segment. Finally, operations 502-508 can also be applied for time segments longer than one inspiratory cycle.
An example of target drive pressure assist ventilation is described in published Canadian patent application No. 2,379,671 (Sinderby et al) filed on July 27, 2000, of which the subject matter is herein incorporated by reference.
Application of negative pressure assist ventilation (102 of Figure 1) First non-restrictive illustrative process for applying a negative pressure around the patient's ribcage and/or abdomen (Figure 6) Operation 601
The simplest method for applying negative pressure around the patient's ribcage and/or abdomen consists of applying a fixed negative pressure around the ribcage and/or abdomen of the patient during inspiration and/or expiration.
Operation 602 Triggering and termination of the application of negative pressure around the patient's ribcage and/or abdomen is synchronized with triggering and termination of the application of positive pressure to the patient's airways.
However, it is within the scope of the present invention to use any other suitable type of control for the triggering and termination of the application of negative pressure around the patient's ribcage and/or abdomen.
Operations 601 and 602 can be performed every inspiratory cycle. The negative pressure application in 601 is not restricted to inspiration only; negative pressure can also be applied during the expiratory phase, where the magnitude of the negative pressure does not have to be same as during the inspiratory phase.
Second non-restrictive illustrative process for applying a negative pressure around the patient's ribcage and/or abdomen (Figure 7)
Operation 701
According to this second non limitative example, neural inspiratory activation is detected through the sensor 205 of Figure 2. For example, the sensor 205 can detect electrical activity of the patient's diaphragm or other respiratory-related muscle. Operation 702
The controller 203 controls the negative pressure ventilator 202 through the level control signal 210 to apply a level of negative pressure around the patient's ribcage and/or abdomen as a function of the detected neural inspiratory activation, for example the electrical activity of the patient's diaphragm. For example, the level of the negative pressure applied around the patient's ribcage and/or abdomen can be proportional to the detected level of neural inspiratory activation. A non-restrictive example of inspiratory proportional pressure assist ventilation is described in the above mentioned US Patent No. 5,820,560 granted to Sinderby et al on October 13, 1998.
Operation 703
Triggering and termination of the application of negative pressure around the patient's ribcage and/or abdomen is synchronized with triggering and termination of the application of positive pressure to the patient's airways. However, it is within the scope of the present invention to use any other suitable type of control for the triggering and termination of the application of negative pressure around the patient's ribcage and/or abdomen.
Operations 701-703 can be performed every inspiratory cycle. Alternatively, the inspiratory cycle can be divided into a plurality of segments and operations 701 and 702 can be performed every cycle segment.
Third non-limitative example of process for applying a negative pressure around the patient's ribcage and/or abdomen (Figure 8)
Operation 801 The non-limitative process of Figure 8 first determines a target level of abdominal pressure swing of the patient. The abdominal pressure swing is the variation of abdominal pressure during a complete cycle of inspiration. For example, the target level of abdominal pressure swing can be determined on the basis of previously measured absolute, peak, mean and/or area/integral values of abdominal pressure swings with or without a range.
In this particular case, the objective is to control the negative pressure assist ventilation so as to reduce the abdominal pressure swing during inspiration. According to this non-restrictive illustrative embodiment, this is achieved by setting a target level of abdominal pressure swing.
Operation 802 The pressure sensor 206 of Figure 2 detect the patient's abdominal pressure during inspiration, using any method known to those of ordinary skill in the art, including those as described in the foregoing description.
Operation 803
The patient's abdominal pressure swing is determined by the controller 203 from the patient's abdominal pressure detected during inspiration through the pressure sensor 206 of Figure 2 (Operation 801). Operation 804
If the controller 203 determines that the detected patient's abdominal pressure swing (Operation 803) is higher than the target level of abdominal pressure swing (Operation 801), Operation 805 is conducted.
Operation 805 The level of negative pressure applied around the ribcage and/or abdomen is increased, for example by a predetermined step.
Operation 806
If the controller 203 determines that the detected patient's abdominal pressure swing (Operation 803) is lower than the target level of abdominal pressure swing (Operation 801), Operation 807 is performed. Operation 807
The level of negative pressure applied around the ribcage and/or abdomen is decreased, for example by a predetermined step. Operation 808
If the controller 203 determines that the detected patient's abdominal pressure swing (Operation 803) is equal to the target level of abdominal pressure swing (Operation 801), Operation 809 is performed.
Operation 809
The level of negative pressure applied around the ribcage and/or abdomen is not changed.
Operation 810
Triggering and termination of the application ot negative pressure around the patient's ribcage and/or abdomen is synchronized with triggering and termination of the application of positive pressure to the patient's airways. However, it is within the scope of the present invention to use any other suitable type of control for the triggering and termination of the application of negative pressure around the patient's ribcage and/or abdomen.
Operations 802-810 can be performed every inspiratory cycle. Alternatively, the inspiratory cycle can be divided into a plurality of segments and operations 802-809 can be performed every cycle segment. Also, operations 802-810 can be performed during time periods longer than one inspiratory cycle.
An example of target drive pressure assist ventilation is described in the above mentioned published Canadian patent application No. 2,379,671 (Sinderby et al) filed on July 27, 2000. It should be mentioned here that a constant Negative End-Expiratory
Pressure (NEEP) can be applied over the abdomen to adjust the end- expiratory lung-volume. NEEP can be applied in combination with inspiratory negative pressure assist ventilation or alone. NEEP can also be delivered in proportional response to tonic inspiratory muscle, for example the diaphragm, activation occurring during expiration.
The above-described, non-restrictive illustrative embodiments of the present invention present, amongst others, the following original features:
1. Combined use of positive and negative pressure assist ventilations;
2. Neurally controlled positive and negative pressure assist ventilations;
3. Neurally triggered and terminated positive and negative pressure assist ventilations; 4. Use of proportionality with positive and negative pressure assist ventilations;
5. Use of target drive during positive and negative pressure assist ventilations; and
6. Specific control of negative pressure assist ventilation via abdominal pressure feedback. Also, the application of both positive and negative pressure assist ventilations presents, amongst others, the following advantages:
- It makes it possible to simultaneously: ■ minimize or optimize inspiratory abdominal pressure swing by applying a negative pressure around the ribcage and/or the abdomen, thus reducing the abdominal load during inspiration, and deliver the required volume of air to the lung by applying an additional positive pressure to the patient's airways.
- A device for carrying out combined positive and negative pressure assist ventilation will not obstruct patient access as negative pressure ventilation alone would, since the positive pressure ventilation could assume 100% of the assist while the negative pressure device is removed during patient access.
- The negative pressure applied around the patient's ribcage and/or abdomen eliminates both the load caused by the ribcage and/or abdomen on the patient's lungs and, thereby, the need for excessive positive pressure applied to the patient's airways. - Cyclic and/or proportional application of negative pressure around the abdomen facilitates diaphragm movement and hence, reduces the risk for airway collapse in the dependent regions of the lungs.
- The positive and negative pressures can be adjusted to avoid application of excessive positive pressure to the patient's airways, and therefore to minimize hemodynamic adverse effects. Monitoring of hemodynamics will help to optimize the level of the negative pressure assist as well as the relative contribution of the positive and negative pressure assists in order to minimize these hemodynamic adverse effects.
Although the present invention has been described in the foregoing description by means of illustrative embodiments thereof, it should be kept in mind that these embodiments can be modified at will within the scope of the appended claims without departing from the spirit and nature of the subject invention.

Claims

WHAT IS CLAIMED IS:
1. A method of delivering combined positive and negative pressure assist ventilation to a patient, comprising: applying a positive pressure to the patient's airways to inflate the patient's lungs; applying a negative pressure around the patient's ribcage and/or abdomen in order to reduce a load imposed by the ribcage and/or abdomen on the patient's lungs; and synchronizing application of the positive and negative pressures.
2. A method of delivering combined positive and negative pressure assist ventilation as defined in claim 1 , wherein synchronising application of the positive and negative pressures comprises: simultaneously applying the positive pressure to the patient's airways and the negative pressure around the patient's ribcage and/or abdomen.
3. A method of delivering combined positive and negative pressure assist ventilation as defined in claim 1 , comprising: adjusting levels of the positive and negative pressures to avoid application of excessive positive pressure to the patient's airways and thereby minimize hemodynamic adverse effects.
4. A method of delivering combined positive and negative pressure assist ventilation as defined in claim 1 , wherein applying a positive pressure to the patient's airways comprises: detecting neural inspiratory activation of the patient; and applying positive pressure to the patient's airways as a function of the detected neural inspiratory activation.
5. A method of delivering combined positive and negative pressure assist ventilation as defined in claim 4, wherein synchronizing application of the positive and negative pressures comprises: synchronizing triggering and termination of the application of the positive pressure to the patient's airways as a function of the detected neural inspiratory activation.
6. A method of delivering combined positive and negative pressure assist ventilation as defined in claim 1 , wherein applying a positive pressure to the patient's airways comprises: determining a target level of neural inspiratory activation of the patient; detecting a level of neural inspiratory activation of the patient; comparing the detected level of neural inspiratory activation with the determined target level; and controlling a level of positive pressure applied to the patient's airways as a function of the comparison.
7. A method of delivering combined positive and negative pressure assist ventilation as defined in claim 6, wherein synchronizing application of the positive and negative pressures comprises: synchronizing triggering and termination of the application of the positive pressure to the patient's airways in relation to the detected level of neural inspiratory activation.
8. A method of delivering combined positive and negative pressure assist ventilation as defined in claim 6, wherein controlling the level of positive pressure applied to the patient's airways comprises: increasing the level of positive pressure applied to the patient's airways when the comparison indicates that the detected level of neural inspiratory activation of the patient is higher than the determined target level.
9. A method of delivering combined positive and negative pressure assist ventilation as defined in claim 6, wherein controlling the level of positive pressure applied to the patient's airways comprises: decreasing the level of positive pressure applied to the patient's airways when the comparison indicates that the detected level of neural inspiratory activation of the patient is lower than the determined target level.
10. A method of delivering combined positive and negative pressure assist ventilation as defined in claim 6, wherein controlling the level of positive pressure applied to the patient's airways comprises: maintaining a present level of positive pressure applied to the patient's airways when the comparison indicates that the detected level of neural inspiratory activation of the patient is equal to the determined target level.
11. A method of delivering combined positive and negative pressure assist ventilation as defined in claim 1 , wherein applying a negative pressure around the patient's ribcage and/or abdomen comprises: applying a constant negative pressure around the patient's ribcage and/or abdomen during patient's inspiration.
12. A method of delivering combined positive and negative pressure assist ventilation as defined in claim 1 , wherein applying a negative pressure around the patient's ribcage and/or abdomen comprises: synchronizing triggering and termination of the application of negative pressure with triggering and termination of the application of positive pressure.
13. A method of delivering combined positive and negative pressure assist ventilation as defined in claim 1 , wherein applying a negative pressure t around the patient's ribcage and/or abdomen comprises: detecting neural inspiratory activation of the patient; and applying the negative pressure around the patient's ribcage and/or abdomen as a function of the detected neural inspiratory activation.
14. A method of delivering combined positive and negative pressure assist ventilation as defined in claim 1 , wherein applying a negative pressure around the patient's ribcage and/or abdomen comprises: determining a target level of an abdominal pressure swing of the patient; detecting a level of abdominal pressure swing of the patient; comparing the detected level of abdominal pressure swing with the determined target level; and controlling a level of negative pressure applied around the patient's ribcage and/or abdomen as a function of the comparison.
15. A method of delivering combined positive and negative pressure assist ventilation as defined in claim 14, wherein controlling the level of negative pressure applied around the patient's ribcage and/or abdomen comprises: increasing the level of negative pressure applied around the patient's ribcage and/or abdomen when the comparison indicates that the detected level of abdominal pressure swing of the patient is higher than the determined target level.
16. A method of delivering combined positive and negative pressure assist ventilation as defined in claim 14, wherein controlling the level of negative pressure applied around the patient's ribcage and/or abdomen comprises: decreasing the level of negative pressure applied around the patient's ribcage and/or abdomen when the comparison indicates that the detected level of abdominal pressure swing of the patient is lower than the determined target level.
17. A method of delivering combined positive and negative pressure assist ventilation as defined in claim 14, wherein controlling the level of negative pressure applied around the patient's ribcage and/or abdomen comprises: maintaining a present level of negative pressure applied around the patient's ribcage and/or abdomen when the comparison indicates that the detected level of abdominal pressure swing of the patient is equal to the determined target level.
18. A method of delivering combined positive and negative pressure assist ventilation as defined in claim 1 , further comprising applying a constant Negative End-Expiratory Pressure over the abdomen to adjust an end-expiratory lung- volume.
19. A method of delivering combined positive and negative pressure assist ventilation as defined in claim 18, comprising applying the constant Negative End- Expiratory Pressure over the abdomen in combination with inspiratory negative pressure assist ventilation.
20. A method of delivering combined positive and negative pressure assist ventilation as defined ih claim 18, comprising applying the constant Negative End- Expiratory Pressure over the abdomen in proportional response to tonic inspiratory muscle activation occurring during expiration.
21. A method of delivering combined positive and negative pressure assist ventilation as defined in claim 1 , wherein applying a negative pressure comprises obtaining an intrathoracic pressure estimate by measuring an airway pressure deflection during a patient's airway occlusion.
22. A method of delivering combined positive and negative pressure assist ventilation as defined in claim 21 , wherein, in case of intrinsic PEEP, obtaining an intrathoracic pressure estimate includes an extrapolation for the period between an onset of electrical activity of the patient's diaphragm activity and an onset of the patient's airway pressure deflection.
23. A system for delivering combined positive and negative pressure assist ventilation to a patient, comprising: a positive pressure ventilator connected to the patient's airways for applying a positive pressure to the patient's airways to inflate the patient's lungs; a negative pressure ventilator installed on the patient's ribcage and/or abdomen for applying a negative pressure around the patient's ribcage and/or abdomen in order to reduce a load imposed by the ribcage and/or abdomen on the patient's lungs; and a controller connected to the positive and negative pressure ventilators for controlling operation of said positive and negative pressure ventilators.
24. A system for delivering combined positive and negative pressure assist ventilation as defined in claim 23, wherein the controller synchronizes operation of the positive and negative pressure- ventilators to apply the positive pressure to the patient's airways and the negative pressure around the patient's ribcage and/or abdomen simultaneously.
25. A system for delivering combined positive and negative pressure assist ventilation as defined in claim 23, comprising a sensor of neural inspiratory activation of the patient, the controller being responsive to the neural inspiratory activation detected by the sensor to control the positive pressure ventilator.
26. A system for delivering combined positive and negative pressure assist ventilation as defined in claim 23, comprising: means for supplying a target level of neural inspiratory activation of the patient; and a sensor of neural inspiratory activation of the patient; wherein the controller comprises a comparator of the detected level of neural inspiratory activation with the determined target level to control the positive pressure ventilator in relation to this comparison.
27. A system for delivering combined positive and negative pressure assist ventilation as defined in claim 23, wherein the controller controls the negative pressure ventilator to apply a constant negative pressure around the patient's ribcage and/or abdomen during patient's inspiration.
28. A system for delivering combined positive and negative pressure assist ventilation as defined in claim 23, comprising: a sensor of neural inspiratory activation of the patient; wherein the controller is responsive to the neural inspiratory activation to control the negative pressure ventilator.
29. A system for delivering combined positive and negative pressure assist ventilation as defined in claim 23, comprising: means for supplying a target level of an abdominal pressure swing of the patient; and a sensor of a level of abdominal pressure swing of the patient; the controller comprising a comparator of the detected level of abdominal pressure swing with the determined target level to control the negative pressure ventilator as a function of the comparison.
30. A system for delivering combined positive and negative pressure assist ventilation to a patient, comprising: first means for applying a positive pressure to the patient's airways to inflate the patient's lungs; second means for applying a negative pressure around the patient's ribcage and/or abdomen in order to reduce a load imposed by the ribcage and/or abdomen on the patient's lungs; and means for synchronizing operation of the first and second pressure- applying means.
31. A system for delivering combined positive and negative pressure assist ventilation as defined in claim 30, wherein the synchronizing means comprises: means for simultaneously applying the positive pressure to the patient's airways and the negative pressure around the patient's ribcage and/or abdomen.
32. A system for delivering combined positive and negative pressure assist ventilation as defined in claim 30, comprising: means for adjusting levels of the positive and negative pressures to avoid application of excessive positive pressure to the patient's airways and thereby minimize hemodynamic adverse effects.
33. A system for delivering combined positive and negative pressure assist ventilation as defined in claim 30, wherein the first means comprises: means for detecting neural inspiratory activation of the patient; and means for applying positive pressure to the patient's airways as a function of the detected neural inspiratory activation.
34. A system for delivering combined positive and negative pressure assist ventilation as defined in claim 33, wherein the synchronizing means comprises: means for synchronizing triggering and termination of the application of the positive pressure to the patient's airways as a function of the detected neural inspiratory activation.
35. A system for delivering combined positive and negative pressure assist ventilation as defined in claim 30, wherein the first means comprises: means for determining a target level of neural inspiratory activation of the patient; means for detecting a level of neural inspiratory activation of the patient; means for comparing the detected level of neural inspiratory activation with the determined target level; and means for controlling a level of positive pressure applied to the patient's airways as a function of the comparison.
36. A system for delivering combined positive and negative pressure assist ventilation as defined in claim 35, wherein the controlling means comprises: means for increasing the level of positive pressure applied to the patient's airways when the comparison indicates that the detected level of neural inspiratory activation of the patient is higher than the determined target level.
37. A system for delivering combined positive and negative pressure assist ventilation as defined in claim 35, wherein the controlling means comprises: means for decreasing the level of positive pressure applied to the patient's airways when the comparison indicates that the detected level of neural inspiratory activation of the patient is lower than the determined target level.
38. A system for delivering combined positive and negative pressure assist ventilation as defined in claim 35, wherein the controlling means comprises: means for maintaining a present level of positive pressure applied to the patient's airways when the comparison indicates that the detected level of neural inspiratory activation of the patient is equal to the determined target level.
39. A system for delivering combined positive and negative pressure assist ventilation as defined in claim 30, wherein the second means comprises: means for applying a constant negative pressure around the patient's ribcage and/or abdomen during patient's inspiration.
40. A system for delivering combined positive and negative pressure assist ventilation as defined in claim 30, wherein the synchronizing means comprises: means for synchronizing triggering and termination of the application of negative pressure with triggering and termination of the application of positive pressure.
41. A system for delivering combined positive and negative pressure assist ventilation as defined in claim 30, wherein the second means comprises: means for detecting neural inspiratory activation of the patient; and means for applying the negative pressure around the patient's ribcage and/or abdomen as a function of the detected neural inspiratory activation.
42. A system for delivering combined positive and negative pressure assist ventilation as defined in claim 30, wherein the second means comprises: means for determining a target level of an abdominal pressure swing of the patient; means for detecting a level of abdominal pressure swing of the patient; means for comparing the detected level of abdominal pressure swing with the determined target level; and means for controlling a level of negative pressure applied around the patient's ribcage and/or abdomen as a function of the comparison.
43. A system for delivering combined positive and negative pressure assist ventilation as defined in claim 42, wherein the controlling means comprises: means for increasing the level of negative pressure applied around the patient's ribcage and/or abdomen when the comparison indicates that the detected level of abdominal pressure swing of the patient is higher than the determined target level.
44. A system for delivering combined positive and negative pressure assist ventilation as defined in claim 42, wherein the controlling means comprises: means for decreasing the level of negative pressure applied around the patient's ribcage and/or abdomen when the comparison indicates that the detected level of abdominal pressure swing of the patient is lower than the determined target level.
45. A system for delivering combined positive and negative pressure assist ventilation as defined in claim 42, wherein the controlling means comprises: means for maintaining a present level of negative pressure applied around the patient's ribcage and/or abdomen when the comparison indicates that the detected level of abdominal pressure swing of the patient is equal to the determined target level.
46. A system for delivering combined positive and negative pressure assist ventilation as defined in claim 30, further comprising means for applying a constant Negative End-Expiratory Pressure over the abdomen to adjust an end- expiratory lung-volume.
47. A system for delivering combined positive and negative pressure assist ventilation as defined in claim 46, wherein the constant Negative End-Expiratory Pressure applying means comprises means for applying the constant Negative End-Expiratory Pressure over the abdomen in combination with inspiratory negative pressure assist ventilation.
48. A system for delivering combined positive and negative pressure assist ventilation as defined in claim 46, .wherein the constant Negative End-Expiratory
Pressure applying means comprises means for applying the constant Negative
End-Expiratory Pressure over the abdomen in proportional response to tonic inspiratory muscle activation occurring during expiration.
49. A system for delivering combined positive and negative pressure assist ventilation as defined in claim 30, wherein the means for applying a negative pressure comprises means for obtaining an intrathoracic pressure estimate by measuring an airway pressure deflection during a patient's airway occlusion.
50. A system for delivering combined positive and negative pressure assist ventilation as defined in claim 49, wherein, in case of intrinsic PEEP, the intrathoracic pressure estimate obtaining means comprises means for conducting an extrapolation of the intrathoracic pressure estimate for the period between an onset of electrical activity of the patient's diaphragm activity and an onset of the patient's airway pressure deflection.
EP04789758.2A 2003-10-23 2004-10-21 Combined positive and negative pressure assist ventilation Active EP1680167B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51444903P 2003-10-23 2003-10-23
PCT/CA2004/001851 WO2005039679A1 (en) 2003-10-23 2004-10-21 Combined positive and negative pressure assist ventilation

Publications (3)

Publication Number Publication Date
EP1680167A1 true EP1680167A1 (en) 2006-07-19
EP1680167A4 EP1680167A4 (en) 2009-04-15
EP1680167B1 EP1680167B1 (en) 2014-07-16

Family

ID=34520210

Family Applications (1)

Application Number Title Priority Date Filing Date
EP04789758.2A Active EP1680167B1 (en) 2003-10-23 2004-10-21 Combined positive and negative pressure assist ventilation

Country Status (3)

Country Link
US (1) US7909034B2 (en)
EP (1) EP1680167B1 (en)
WO (1) WO2005039679A1 (en)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7594508B2 (en) * 2006-07-13 2009-09-29 Ric Investments, Llc. Ventilation system employing synchronized delivery of positive and negative pressure ventilation
US8251876B2 (en) 2008-04-22 2012-08-28 Hill-Rom Services, Inc. Breathing exercise apparatus
WO2009149357A1 (en) 2008-06-06 2009-12-10 Nellcor Puritan Bennett Llc Systems and methods for ventilation in proportion to patient effort
US8302602B2 (en) 2008-09-30 2012-11-06 Nellcor Puritan Bennett Llc Breathing assistance system with multiple pressure sensors
JP5583454B2 (en) * 2009-04-13 2014-09-03 チェスト株式会社 Respiratory impedance measuring device and respiratory impedance display method
US8783250B2 (en) 2011-02-27 2014-07-22 Covidien Lp Methods and systems for transitory ventilation support
US8714154B2 (en) 2011-03-30 2014-05-06 Covidien Lp Systems and methods for automatic adjustment of ventilator settings
US9364624B2 (en) 2011-12-07 2016-06-14 Covidien Lp Methods and systems for adaptive base flow
US9498589B2 (en) 2011-12-31 2016-11-22 Covidien Lp Methods and systems for adaptive base flow and leak compensation
US9022031B2 (en) 2012-01-31 2015-05-05 Covidien Lp Using estimated carinal pressure for feedback control of carinal pressure during ventilation
US9180271B2 (en) 2012-03-05 2015-11-10 Hill-Rom Services Pte. Ltd. Respiratory therapy device having standard and oscillatory PEP with nebulizer
US8844526B2 (en) 2012-03-30 2014-09-30 Covidien Lp Methods and systems for triggering with unknown base flow
US9757501B2 (en) * 2012-04-13 2017-09-12 Board Of Regents, The University Of Texas System Methods and apparatus for lowering intracranial and intraspinal cord pressure
US10362967B2 (en) 2012-07-09 2019-07-30 Covidien Lp Systems and methods for missed breath detection and indication
US9492629B2 (en) 2013-02-14 2016-11-15 Covidien Lp Methods and systems for ventilation with unknown exhalation flow and exhalation pressure
US9981096B2 (en) 2013-03-13 2018-05-29 Covidien Lp Methods and systems for triggering with unknown inspiratory flow
DE212014000239U1 (en) 2013-12-30 2016-09-26 St. Michael's Hospital System and inflatable device for applying negative pressure ventilation during respiratory arrest
WO2015192118A1 (en) * 2014-06-13 2015-12-17 The Regent Of The University Of Michigan Systems with control mechanism for negative pressure and positive pressure for optimization of ventilation, central hemodynamics, and vital organ perfusion
US10105281B1 (en) * 2014-06-16 2018-10-23 Trudell Medical International Negative pressure vest
US9808591B2 (en) 2014-08-15 2017-11-07 Covidien Lp Methods and systems for breath delivery synchronization
US9950129B2 (en) 2014-10-27 2018-04-24 Covidien Lp Ventilation triggering using change-point detection
US9925346B2 (en) 2015-01-20 2018-03-27 Covidien Lp Systems and methods for ventilation with unknown exhalation flow
US11179098B2 (en) * 2015-02-23 2021-11-23 Norman A. Paradis System for dynamically stabilizing the chest wall after injury, fracture, or operative procedures
US11247015B2 (en) 2015-03-24 2022-02-15 Ventec Life Systems, Inc. Ventilator with integrated oxygen production
US10315002B2 (en) 2015-03-24 2019-06-11 Ventec Life Systems, Inc. Ventilator with integrated oxygen production
CN107735135B (en) 2015-04-02 2020-06-26 希尔-罗姆服务私人有限公司 Manifold for a respiratory device
US10478375B2 (en) 2015-09-25 2019-11-19 Peter Antros Pulmonary expansion therapy devices
US20200268601A1 (en) * 2015-09-25 2020-08-27 Delta Dynamics Llc System and methods for pulmonary expansion therapy (pxt)
US10773049B2 (en) 2016-06-21 2020-09-15 Ventec Life Systems, Inc. Cough-assist systems with humidifier bypass
CA3075962A1 (en) * 2017-09-17 2019-03-21 Glenn Fernandes Lung cleansing apparatus and method
WO2019100152A1 (en) * 2017-11-21 2019-05-31 The Hospital For Sick Children Device for producing continuous negative abdominal pressure
US11484466B2 (en) * 2017-11-21 2022-11-01 The Hospital For Sick Children Device for producing continuous negative abdominal pressure
US11191915B2 (en) 2018-05-13 2021-12-07 Ventec Life Systems, Inc. Portable medical ventilator system using portable oxygen concentrators
EP3793656A1 (en) 2018-05-14 2021-03-24 Covidien LP Systems and methods for respiratory effort detection utilizing signal distortion
EP3852854A4 (en) * 2018-09-19 2022-06-15 St. Michael's Hospital Systems, devices and methods for modulating a respiratory drive of a patient
US11752287B2 (en) 2018-10-03 2023-09-12 Covidien Lp Systems and methods for automatic cycling or cycling detection
EP3897505A4 (en) * 2018-12-17 2022-09-21 The Trustees of The University of Pennsylvania Improvements on ambulatory respiratory assist device
CN111419681A (en) * 2020-04-08 2020-07-17 青岛科而泰环境控制技术有限公司 Auxiliary breathing machine
US11839587B1 (en) 2023-02-03 2023-12-12 RightAir, Inc. Systems, devices, and methods for ambulatory respiration assistance

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2822803A (en) * 1954-05-18 1958-02-11 Conitech Ltd Artificial respiration apparatus
US3037498A (en) * 1957-08-29 1962-06-05 Shampaine Ind Inc Control systems for mechanical respirators
US3333581A (en) * 1964-03-27 1967-08-01 Elbert W Robinson Pulmonary resuscitator with electrical control system
US4930498A (en) * 1986-02-04 1990-06-05 Dranez Anstalt Ventilator apparatus and fluid control valve
US5820560A (en) * 1995-03-31 1998-10-13 Universite De Montreal Inspiratory proportional pressure assist ventilation controlled by a diaphragm electromyographic signal
US6273088B1 (en) * 1997-06-13 2001-08-14 Sierra Biotechnology Company Lc Ventilator biofeedback for weaning and assistance

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2648331A (en) * 1950-02-01 1953-08-11 Bennett Vivian Ray Means for applying artificial respiration
US4257407A (en) 1977-10-21 1981-03-24 Macchi Pier G Negative pressure respirator shells
US4481938A (en) * 1981-10-16 1984-11-13 Lindley John E Resuscitator, respirator and/or incubator
JPH01223966A (en) 1988-03-01 1989-09-07 Sumitomo Bakelite Co Ltd Respirator
US5299599A (en) 1992-09-17 1994-04-05 Lifecare International, Inc. Valving arrangement for a negative pressure ventilator
US5749830A (en) 1993-12-03 1998-05-12 Olympus Optical Co., Ltd. Fluorescent endoscope apparatus
US5513631A (en) * 1995-07-21 1996-05-07 Infrasonics, Inc. Triggering of patient ventilator responsive to a precursor signal
US5871008A (en) 1995-10-06 1999-02-16 Massachusetts Institute Of Technology Miniature high-frequency ventilator
US5806512A (en) * 1996-10-24 1998-09-15 Life Support Technologies, Inc. Cardiac/pulmonary resuscitation method and apparatus
US6588423B1 (en) 1998-02-27 2003-07-08 Universite De Montreal Method and device responsive to myoelectrical activity for triggering ventilatory support
SE9800855D0 (en) * 1998-03-16 1998-03-16 Siemens Elema Ab Apparatus for improving gas distribution
US6962155B1 (en) 1999-07-30 2005-11-08 Universite De Montreal Target drive ventilation gain controller and method
ITMI20021502A1 (en) 2002-07-09 2004-01-09 Starmed Srl ARTIFICIAL BREATHING DEVICE WITHOUT THE HELMET OF MASKS, PARTICULARLY FOR INFANTS AND INFANTS

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2822803A (en) * 1954-05-18 1958-02-11 Conitech Ltd Artificial respiration apparatus
US3037498A (en) * 1957-08-29 1962-06-05 Shampaine Ind Inc Control systems for mechanical respirators
US3333581A (en) * 1964-03-27 1967-08-01 Elbert W Robinson Pulmonary resuscitator with electrical control system
US4930498A (en) * 1986-02-04 1990-06-05 Dranez Anstalt Ventilator apparatus and fluid control valve
US5820560A (en) * 1995-03-31 1998-10-13 Universite De Montreal Inspiratory proportional pressure assist ventilation controlled by a diaphragm electromyographic signal
US6273088B1 (en) * 1997-06-13 2001-08-14 Sierra Biotechnology Company Lc Ventilator biofeedback for weaning and assistance

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2005039679A1 *

Also Published As

Publication number Publication date
WO2005039679A1 (en) 2005-05-06
EP1680167B1 (en) 2014-07-16
EP1680167A4 (en) 2009-04-15
US20080115786A1 (en) 2008-05-22
US7909034B2 (en) 2011-03-22

Similar Documents

Publication Publication Date Title
US7909034B2 (en) Combined positive and negative pressure assist ventilation
JP4667693B2 (en) Synchronizing patient and ventilator using two phase sensors
US7055522B2 (en) Patient-ventilator synchronization using dual phase sensors
JP5735053B2 (en) A device that achieves equilibrium against the inherent positive end expiratory pressure
JP2022002732A5 (en)
EP1973470B1 (en) System for determining dynamically respiratory features in spontaneously breathing patients receiving mechanical ventilatory assist
JP4613213B2 (en) A device that monitors the biomechanical movement of the respiratory organ of a subject and controls the ventilator based on the biomechanical movement
US8316847B2 (en) Automatic positive airway pressure therapy through the nose or mouth for treatment of sleep apnea and other respiratory disorders
JPS58159762A (en) Artificial respirator
JP2011502611A (en) How to trigger a ventilator
WO2000045880A1 (en) Method and apparatus for controlling a medical ventilator
US9981098B2 (en) Apparatus for assisted ventilation and corresponding regulation method
US9386952B2 (en) Method and device(s) for diagnosis and/or treatment of sleep apnea and related disorders
JP2010214024A (en) Respiratory exercise support device
CN111543999A (en) System for sensing respiratory effort of a patient
JP4464520B2 (en) Intermittent positive pressure ventilator
JP2018518293A (en) Positive pressure pulse cardiopulmonary resuscitation device
JPH05115554A (en) Method and device for ratio aid type artificial respiration
AU2010201464B2 (en) Automatic Positive Airway Pressure Therapy through the Nose or Mouth for Treatment of Sleep Apnea and Other Respiratory Disorders
Rossi Intrinsic PEEP
Marković et al. PAV+ OR NAVA. WHAT IS BETTER?

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20060504

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20090318

17Q First examination report despatched

Effective date: 20090807

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

INTG Intention to grant announced

Effective date: 20140204

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 677185

Country of ref document: AT

Kind code of ref document: T

Effective date: 20140815

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602004045476

Country of ref document: DE

Effective date: 20140821

REG Reference to a national code

Ref country code: NL

Ref legal event code: VDEP

Effective date: 20140716

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 677185

Country of ref document: AT

Kind code of ref document: T

Effective date: 20140716

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20141017

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140716

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140716

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20141117

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140716

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20141016

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140716

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140716

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140716

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140716

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602004045476

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140716

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140716

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140716

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140716

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140716

Ref country code: IT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140716

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20141021

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140716

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

26N No opposition filed

Effective date: 20150417

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20141021

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20141031

REG Reference to a national code

Ref country code: IE

Ref legal event code: MM4A

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20141031

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20141031

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20141021

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20141021

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 12

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140716

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140716

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO

Effective date: 20041021

Ref country code: BE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140716

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 13

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 14

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 15

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20230921

Year of fee payment: 20

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20230906

Year of fee payment: 20